The new prostate cancer blood test with 94 per cent accuracy



The new prostate cancer blood test with 94 per cent accuracy

Researchers have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods. New research shows that the Prostate Screening EpiSwitch (PSE) blood test is 94 per cent accurate — beating the currently used prostate-specific antigen (PSA) blood test. The research team say that the new test shows significant potential as an accurate and rapid cancer screening diagnostic.

Materials provided by University of East Anglia. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

18th March 2023

New combination of drugs works together to reduce lung tumors in mice

Read more
17th March 2023

Study offers a potential strategy to improve T cell therapy in solid tumors

Read more
17th March 2023

Researchers chart a course for understanding, preventing, and treating young-onset colorectal cancer

Read more